Chemopreventive strategies are very attractive and have earned serious
consideration as a potential means of controlling cancer incidence. H
ow ever, the use of some anti-initiating entities (enzyme inducers or
inhibitors) devised to reduce tumor initiation is controversial. Indee
d, considering the double-edged-sword (activating or detoxifying) natu
re of drug metabolizing enzymes, any attempt to modulate such catalyst
s by dietary components (including drugs) may lead to cancer risk.